HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical value of a mucin-like carcinoma-associated antigen (MCA) in patients with carcinomas of the kidney and the urinary collecting system.

Abstract
A new tumor marker, mucin-like carcinoma-associated antigen (MCA), was evaluated in thirty-four patients with renal cell carcinomas and forty patients with carcinomas of the urinary collecting system. In the first group, specificity was 95%, sensitivity 65%, the predictive value for positive diagnosis was 94%, and for negative diagnosis 72%. In the second group specificity was 83%, sensitivity 71%, predictive value for positive diagnosis was 63%, and for negative diagnosis 88%. Receiver operating characteristic curves indicated that the maximum amount of information was greater in patients of the first group than the second (0.379 vs. 0.332 bits). In the light of these data, the MCA test can be recommended for assessing metastatic spread in patients particularly with renal cell carcinomas.
AuthorsA R Miserez, J Müller-Brand, M Rist, H Mäcke
JournalThe International journal of biological markers (Int J Biol Markers) 1991 Jan-Mar Vol. 6 Issue 1 Pg. 7-11 ISSN: 0393-6155 [Print] United States
PMID1856518 (Publication Type: Journal Article)
Chemical References
  • Antigens, Neoplasm
  • Antigens, Tumor-Associated, Carbohydrate
  • Biomarkers, Tumor
  • mucinous carcinoma-associated antigen
Topics
  • Analysis of Variance
  • Antigens, Neoplasm (blood)
  • Antigens, Tumor-Associated, Carbohydrate
  • Biomarkers, Tumor (blood)
  • Carcinoma, Renal Cell (blood, diagnosis, secondary)
  • Carcinoma, Transitional Cell (blood, diagnosis, secondary)
  • Humans
  • Immunoenzyme Techniques
  • Kidney Neoplasms (blood, diagnosis)
  • Predictive Value of Tests
  • Urologic Neoplasms (blood, diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: